Published in J Virol on June 01, 2005
Foamy virus biology and its application for vector development. Viruses (2011) 1.38
Molecular biology of foamy viruses. Med Microbiol Immunol (2010) 1.16
Subviral particle release determinants of prototype foamy virus. J Virol (2008) 0.95
Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release. J Virol (2005) 0.94
Glycosylation modulates arenavirus glycoprotein expression and function. Virology (2010) 0.86
Foamy virus budding and release. Viruses (2013) 0.81
Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain. J Virol (2006) 0.81
Early events in foamy virus-host interaction and intracellular trafficking. Viruses (2013) 0.79
Cocirculation of Two env Molecular Variants, of Possible Recombinant Origin, in Gorilla and Chimpanzee Simian Foamy Virus Strains from Central Africa. J Virol (2015) 0.77
Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol (1987) 11.36
Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer (1974) 6.53
Folding and assembly of viral membrane proteins. Virology (1993) 4.63
Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol (2003) 2.42
Foamy virus capsids require the cognate envelope protein for particle export. J Virol (1999) 2.30
Foamy virus particle formation. J Virol (1998) 2.22
Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J Virol (1997) 1.90
A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J Virol (2001) 1.80
Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing. J Virol (1998) 1.67
Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of Moloney murine leukemia virus. J Virol (1992) 1.64
Functional analysis of human foamy virus accessory reading frames. J Virol (1993) 1.59
Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells. Hum Gene Ther (2003) 1.58
Mutational analysis of N-linked glycosylation sites of Friend murine leukemia virus envelope protein. J Virol (1991) 1.48
Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer. Virology (1996) 1.45
The replication strategy of foamy viruses. Curr Top Microbiol Immunol (2003) 1.41
The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization. Virology (2002) 1.41
Comparative sequence analysis and predictions for the envelope glycoproteins of foamy viruses. J Gen Virol (1999) 1.31
Specific interaction of a novel foamy virus Env leader protein with the N-terminal Gag domain. J Virol (2001) 1.24
An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity. J Virol (2000) 1.23
Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity. J Virol (2004) 1.14
The intact retroviral Env glycoprotein of human foamy virus is a trimer. J Virol (2000) 1.13
The foamy virus envelope glycoproteins. Curr Top Microbiol Immunol (2003) 1.13
Features of the Env leader protein and the N-terminal Gag domain of feline foamy virus important for virus morphogenesis. Virology (2003) 1.12
Functions of HIV envelope glycans. Trends Biochem Sci (1994) 1.08
Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1. Glycobiology (2001) 0.97
Furin-mediated cleavage of the feline foamy virus Env leader protein. J Virol (2004) 0.95
The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. J Gen Virol (1995) 0.93
A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology (2003) 3.04
A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol (2012) 2.71
Rapid Diagnosis of Infection in the Critically Ill, a Multicenter Study of Molecular Detection in Bloodstream Infections, Pneumonia, and Sterile Site Infections. Crit Care Med (2015) 2.37
Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther (2007) 1.85
Improved primate foamy virus vectors and packaging constructs. J Virol (2002) 1.65
Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells. Hum Gene Ther (2003) 1.58
Real-time PCR for diagnosis of human bocavirus infections and phylogenetic analysis. J Clin Microbiol (2007) 1.52
HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high. PLoS One (2011) 1.45
Quantitative analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane. J Cell Biol (2012) 1.44
Evidence of recombination in the norovirus capsid gene. J Virol (2005) 1.41
Foamy virus biology and its application for vector development. Viruses (2011) 1.38
A simple and rapid single-step multiplex RT-PCR to detect Norovirus, Astrovirus and Adenovirus in clinical stool samples. J Virol Methods (2004) 1.38
Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer. Arthritis Res Ther (2009) 1.34
Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis. J Virol (2006) 1.33
Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles. Retrovirology (2010) 1.32
Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method. Clin Diagn Lab Immunol (2003) 1.28
Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response. Cell Rep (2013) 1.28
Genome-wide mapping of foamy virus vector integrations into a human cell line. J Gen Virol (2006) 1.28
Feline foamy virus genome and replication strategy. J Virol (2003) 1.25
Phylogenetic diversity and low level antiretroviral resistance mutations in HIV type 1 treatment-naive patients from Cape Town, South Africa. AIDS Res Hum Retroviruses (2008) 1.23
Restriction of diverse retroviruses by SAMHD1. Retrovirology (2013) 1.23
Pregenomic RNA is required for efficient incorporation of pol polyprotein into foamy virus capsids. J Virol (2002) 1.22
Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cells. J Immunol (2012) 1.21
RNA and protein requirements for incorporation of the Pol protein into foamy virus particles. J Virol (2005) 1.20
Restriction of foamy viruses by primate Trim5alpha. J Virol (2008) 1.19
The production of cleaved, trimeric human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein vaccine antigens and infectious pseudoviruses using linear polyethylenimine as a transfection reagent. Protein Expr Purif (2006) 1.19
Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity. J Virol (2005) 1.18
Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis. J Virol (2010) 1.17
Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process. J Virol (2003) 1.16
Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity. J Virol (2004) 1.14
Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet. J Biol Chem (2008) 1.12
Overexpression of cdk4 and cyclinD1 triggers greater expansion of neural stem cells in the adult mouse brain. J Exp Med (2011) 1.09
Heparan sulfate is an attachment factor for foamy virus entry. J Virol (2012) 1.07
The influence of semen-derived enhancer of virus infection on the efficiency of retroviral gene transfer. J Gene Med (2010) 1.05
Regulation of foamy virus protease activity by viral RNA: a novel and unique mechanism among retroviruses. J Virol (2011) 1.03
Prototype foamy virus gag nuclear localization: a novel pathway among retroviruses. J Virol (2011) 1.03
Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell. Mol Biol Cell (2003) 1.02
Structure-activity relationships of flavonoid-induced cytotoxicity on human leukemia cells. Arch Biochem Biophys (2007) 1.00
Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome. J Virol (2007) 1.00
Foamy virus nuclear RNA export is distinct from that of other retroviruses. J Virol (2010) 0.98
A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors. Mol Ther (2012) 0.97
The complete nucleotide sequence of a New World simian foamy virus. Virology (2007) 0.97
Orthoretroviral-like prototype foamy virus Gag-Pol expression is compatible with viral replication. Retrovirology (2011) 0.96
Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines. PLoS Pathog (2011) 0.95
Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases. Retrovirology (2010) 0.95
AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP. Nucleic Acids Res (2007) 0.95
Subviral particle release determinants of prototype foamy virus. J Virol (2008) 0.95
CpG oligodeoxynucleotides activate HIV replication in latently infected human T cells. J Biol Chem (2004) 0.94
Differential effect of acute and permanent heat shock protein 70 overexpression in tumor cells on lysability by cytotoxic T lymphocytes. Cancer Res (2003) 0.94
N-terminal Gag domain required for foamy virus particle assembly and export. J Virol (2005) 0.94
Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release. J Virol (2005) 0.94
Foamy virus envelope glycoprotein is sufficient for particle budding and release. J Virol (2003) 0.93
TRPV channels mediate temperature-sensing in human corneal endothelial cells. Exp Eye Res (2010) 0.93
Noncanonical microRNA (miRNA) biogenesis gives rise to retroviral mimics of lymphoproliferative and immunosuppressive host miRNAs. MBio (2014) 0.92
Accuracy estimation of foamy virus genome copying. Retrovirology (2009) 0.92
Generation of an improved foamy virus vector by dissection of cis-acting sequences. J Gen Virol (2009) 0.90
A unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral matrix and capsid. PLoS Pathog (2013) 0.90
Differential pH-dependent cellular uptake pathways among foamy viruses elucidated using dual-colored fluorescent particles. Retrovirology (2012) 0.89
Inhibition of NADPH oxidase by apocynin inhibits lipopolysaccharide (LPS) induced up-regulation of arginase in rat alveolar macrophages. Eur J Pharmacol (2007) 0.89
The prototype foamy virus protease is active independently of the integrase domain. Retrovirology (2012) 0.89
Prototype foamy virus protease activity is essential for intraparticle reverse transcription initiation but not absolutely required for uncoating upon host cell entry. J Virol (2013) 0.89
High-efficiency gene transfer into cultured embryonic motoneurons using recombinant lentiviruses. Histochem Cell Biol (2006) 0.89
Activation of transgenic estrogen receptor-beta by selected phytoestrogens in a stably transduced rat serotonergic cell line. J Steroid Biochem Mol Biol (2010) 0.88
Activation-induced depletion of protein kinase C alpha provokes desensitization of monocytes/macrophages in sepsis. J Immunol (2005) 0.88
Determinants of foamy virus envelope glycoprotein mediated resistance to superinfection. Virology (2003) 0.87
Contrasting contributions of complementarity-determining region 2 and hypervariable region 4 of rat BV8S2+ (Vbeta8.2) TCR to the recognition of myelin basic protein and different types of bacterial superantigens. Int Immunol (2004) 0.87
Retrotransposition and cell-to-cell transfer of foamy viruses. J Virol (2003) 0.86
Determination of the relative amounts of Gag and Pol proteins in foamy virus particles. Retrovirology (2005) 0.86
Complex effects of foamy virus central purine-rich regions on viral replication. Virology (2008) 0.85
Retroviral vectors containing Tet-controlled bidirectional transcription units for simultaneous regulation of two gene activities. J Mol Genet Med (2006) 0.85
Virus detection and semiquantitation in explanted heart tissues of idiopathic dilated cardiomyopathy adult patients by use of PCR coupled with mass spectrometry analysis. J Clin Microbiol (2013) 0.83
AZT-resistant foamy virus. Virology (2007) 0.83
Characterisation of a chikungunya virus from a German patient returning from Mauritius and development of a serological test. Med Microbiol Immunol (2008) 0.83
Foamy virus integration. J Virol (2004) 0.83
Transduction of human glial and neuronal tumor cells with different lentivirus vector pseudotypes. J Neurooncol (2004) 0.82
Foamy virus for efficient gene transfer in regeneration studies. BMC Dev Biol (2013) 0.82
Foamy virus budding and release. Viruses (2013) 0.81
Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain. J Virol (2006) 0.81
Dual activity of phosphorothioate CpG oligodeoxynucleotides on HIV: reactivation of latent provirus and inhibition of productive infection in human T cells. Ann N Y Acad Sci (2006) 0.81